Drugs for COVID-19: An Update

Fecha de publicación: 01/01/2022

Autores de IIS La Fe

Inmaculada Andreu Ros

Autor

Participantes ajenos a IIS La Fe

Ceramella J.
Iacopetta D.
Sinicropi M.S.
Mariconda A.
Saturnino C.
Giuzio F.
Longo P.
Aquaro S.
Catalano A.

Grupos

Unidad Mixta de Investigación en Mecanismos moleculares de las Reacciones adversas de fármacos

Abstract

The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) was the seventh known human coronavirus, and it was identified in Wuhan, Hubei province, China, in 2020. It caused the highly contagious disease called coronavirus disease 2019 (COVID-19), declared a global pandemic by the World Health Organization (WHO) on 11 March 2020. A great number of studies in the search of new therapies and vaccines have been carried out in these three long years, producing a series of successes; however, the need for more effective vaccines, therapies and other solutions is still being pursued. This review represents a tracking shot of the current pharmacological therapies used for the treatment of COVID-19. © 2022 by the authors.

Datos de la publicación

ISSN/ISSNe:: 1420-3049, 1420-3049
Tipo:: Review
Páginas:: -
DOI:: 10.3390/molecules27238562
PubMed:: 36500655
Enlace a otro recurso:: www.scopus.com
Factor de Impacto:: 0,705 SCImago ℠
Cuartil:: Q1 SCImago ℠

Documentos

No hay documentos

Métricas

Filiaciones

Ceramella J.:: Department of Pharmacy, Health and Nutritional Sciences, University of Calabria, Arcavacata di Rende, Rende, 87036, Italy
Iacopetta D.:: Department of Pharmacy, Health and Nutritional Sciences, University of Calabria, Arcavacata di Rende, Rende, 87036, Italy
Sinicropi M.S.:: Department of Pharmacy, Health and Nutritional Sciences, University of Calabria, Arcavacata di Rende, Rende, 87036, Italy
Andreu I.:: Departamento de Química, Universitat Politècnica de València, Camino de Vera s/n, Valencia, 46022, Spain

Unidad Mixta de Investigación UPV-IIS La Fe, Hospital Universitari i Politècnic La Fe, Avenida de Fernando Abril Martorell 106, Valencia, 46026, Spain
Mariconda A.:: Department of Science, University of Basilicata, Potenza, 85100, Italy
Saturnino C.:: Department of Science, University of Basilicata, Potenza, 85100, Italy
Giuzio F.:: Department of Science, University of Basilicata, Potenza, 85100, Italy
Longo P.:: Department of Chemistry and Biology, University of Salerno, Via Giovanni Paolo II, 132, Fisciano, 84084, Italy
Aquaro S.:: Department of Pharmacy, Health and Nutritional Sciences, University of Calabria, Arcavacata di Rende, Rende, 87036, Italy
Catalano A.:: Department of Pharmacy-Drug Sciences, University of Bari “Aldo Moro”, Bari, 70126, Italy

Keywords

China; COVID-19; Humans; Pandemics; SARS-CoV-2; Vaccines; vaccine; China; human; pandemic

Cita

Cita Bibliográfica